SOCMA hosted a roundtable on August 17 to address operational best practices and legal challenges around vaccine mandates, as the Delta Variant continues to change the trajectory of recovery from COVID-19.
Lonza and Moderna Enter New Agreement to Double Drug Substance Production for COVID-19 Vaccine in Visp
Lonza today announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to manufacture the drug substance for the COVID-19 Vaccine Moderna.
As SOCMA continues to keep a pulse on the specialty and fine chemical industry, we understand that companies across the industry are grappling with how to encourage employee inoculations now that there’s increased availability of COVID-19 vaccines. We’ve spoken with leaders from Texas to Rhode Island and everywhere in between about how they are handling the vaccination within their companies, and here are a few takeaways you can consider when implementing your own plans.
With an unprecedented economic shutdown during the first half of 2020, many companies scrambled to adjust their business models and product lines to survive. Polysciences, Inc. and AVATAR shared their approach for overcoming business challenges and leveraging the opportunities that have unfolded throughout the year.
Customer letter from Advanced Chemical Concepts to address COVID-19 challenges.
SOCMA has gathered information on high-demand products used to combat COVID-19 and partnered with EchoSystem to support B2B connection.
Customer letter from Hydrite Chemical Co. to address COVID-19 challenges.
Customer letter from McGriff, Seibels & Williams, Inc. to address COVID-19 challenges.
Customer letter from Charkit Chemical Company, LLC, to address COVID-19 challenges.
Customer letter from Halocarbon Products Corporation to address COVID-19 related challenges.